ロード中...
Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study
Aims: To assess real-world effectiveness and safety of intravenous (IV) HX575, a biosimilar epoetin-α, in hemodialysis (HD) patients. Materials and methods: This prospective, observational, pharmacoepidemiological study of adult HD patients treated with IV HX575 for renal anemia for up to 24 months...
保存先:
| 出版年: | Clin Nephrol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dustri-Verlag Dr. Karl Feistle
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5735817/ https://ncbi.nlm.nih.gov/pubmed/29168688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CN109245 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|